CL2010001274A1 - Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona y ácido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico; kit farmacéutico; y uso en enfermedades de proliferación celular - Google Patents

Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona y ácido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico; kit farmacéutico; y uso en enfermedades de proliferación celular

Info

Publication number: CL2010001274A1
Authority: CL; Chile
Prior art keywords: amino; methyl; indolinone; methylcarbonyl; anilino
Prior art date: 2008-06-06

Application number

CL2010001274A

Other languages

English (en)

Spanish (es)

Inventor

Frank Hilberg

Rolf Kaiser

Martin Friedrich Stefanic

David Shapiro

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-06

Filing date

2010-11-19

Publication date

2011-05-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66221453&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2010001274(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-11-19 Application filed filed Critical

2011-05-13 Publication of CL2010001274A1 publication Critical patent/CL2010001274A1/es

Links

239000002253 acid Substances 0.000 title abstract 2
230000004663 cell proliferation Effects 0.000 title abstract 2
201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
CPMDPSXJELVGJG-UHFFFAOYSA-N methyl 2-hydroxy-3-[N-[4-[methyl-[2-(4-methylpiperazin-1-yl)acetyl]amino]phenyl]-C-phenylcarbonimidoyl]-1H-indole-6-carboxylate Chemical compound OC=1NC2=CC(=CC=C2C=1C(=NC1=CC=C(C=C1)N(C(CN1CCN(CC1)C)=O)C)C1=CC=CC=C1)C(=O)OC CPMDPSXJELVGJG-UHFFFAOYSA-N 0.000 title abstract 2
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 title 1
150000003839 salts Chemical class 0.000 abstract 2
WBXPDJSOTKVWSJ-ZDUSSCGKSA-N pemetrexed Chemical compound C=1NC=2NC(N)=NC(=O)C=2C=1CCC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 WBXPDJSOTKVWSJ-ZDUSSCGKSA-N 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CL2010001274A 2008-06-06 2010-11-19 Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona y ácido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico; kit farmacéutico; y uso en enfermedades de proliferación celular CL2010001274A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP08157749		2008-06-06
US7888208P	2008-07-08	2008-07-08

Publications (1)

Publication Number	Publication Date
CL2010001274A1 true CL2010001274A1 (es)	2011-05-13

Family

ID=66221453

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2010001274A CL2010001274A1 (es)	2008-06-06	2010-11-19	Combinación farmacéutica que comprende 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)anilino)-1-fenil-metileno]-6-metoxicarbonil-2-indolinona y ácido n-[4-[2-(2-amino-4,7-dihidro-4-oxo-1h-pirrolo[2,3-d]pirimidin-5-il)etil)benzoil)-l-glutámico; kit farmacéutico; y uso en enfermedades de proliferación celular

Country Status (3)

Country	Link
BR (1)	BRPI0913231A2 (pt)
CL (1)	CL2010001274A1 (pt)
NO (1)	NO2985025T3 (pt)

2009
- 2009-06-04 BR BRPI0913231A patent/BRPI0913231A2/pt not_active Application Discontinuation
- 2009-06-04 NO NO15179438A patent/NO2985025T3/no unknown
2010
- 2010-11-19 CL CL2010001274A patent/CL2010001274A1/es unknown

Also Published As

Publication number	Publication date
BRPI0913231A2 (pt)	2019-08-27
NO2985025T3 (pt)	2018-06-16

Similar Documents

Publication	Publication Date	Title
UY30136A1 (es)	2007-09-28	Sal especifica, forma anhidra y cristalina de un derivado de dihidropteridiona
TW200831103A (en)	2008-08-01	Crystalline forms of pemetrexed diacid and processes for the preparation thereof
ATE430754T1 (de)	2009-05-15	Phosphororganische indazolderivate und deren verwendung als proteinkinaseinhibitoren
EG24562A (en)	2009-10-25	3-Z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
ATE433979T1 (de)	2009-07-15	Mit einem 6,6-bicyclischen ring substituierte heterobicyclische proteinkinaseinhibitoren
DE60325761D1 (de)	2009-02-26	Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren
SG170785A1 (en)	2011-05-30	Benzothiazoles having histamine h3 receptor activity
NO20044137L (no)	2004-11-25	Aminoindazolderivater, deres fremstilling og anvendelse samt mellomprodukter
EA201000145A1 (ru)	2010-06-30	Кристаллические формы 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино)бензамида
GT200400206A (es)	2005-10-06	Pirimidinas sustituidas con sulfoximina como inhibidores de cdk y/o vegf, su preparacion y sus usos como medicamento.
NO20082249L (no)	2008-07-18	Fusert heterocyklisk derivat, medisinsk sammensetning inneholdende samme samt medisinsk bruk derav
BRPI0820474B8 (pt)	2021-05-25	uso do composto 1-[2-(2,4-dimetil-fenil-sulfanil)-fenil]-piperazina ou de sais farmaceuticamente aceitáveis do mesmo
ECSP109890A (es)	2010-03-31	Particulas de un antagonista de crth2
AR065797A1 (es)	2009-07-01	Usos y derivados de 1-(2- (2,4- dimetilfenilsulfanil) fenil) piperazina
LTC1632232I2 (lt)	2024-09-10	4[[4-[[4-(2-cianoetenil)-2,6-dimetilfenil]amino]-2-pirimidinil]amino]benzonitrilo druska
SMT201300108B (it)	2013-11-08	Nuove composizioni di 1-Ä2-(2,4-dimetilfenil solfanil)-fenilÜ piperazina
CL2011003138A1 (es)	2012-06-22	N-(protegido- n-(3-metoxi-5-metilpirazon-2-il)-2-(4-[1,3,4-oxadiazol-2-il]fenil)piridino-3-sulfonamida y su proceso de preparacion.
NO20025123L (no)	2003-09-22	Vann-silisiumoksyd-suspensjoner for bruk i brönnsement
DE602004027354D1 (de)	2010-07-08	SUBSTITUIERTE 8y-PYRIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ON- UND 8y-PYRIMIDINYLDIHYDROSPIROiCYCLOALKYL PYRIMIDOi1,2-A PYRIMIDIN-6-ONDERIVATE UND DEREN VERWENDUNG BEI NEURODEGENERATIVEN KRANKHEITEN
DK1581518T3 (da)	2011-06-06	Substituerede 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazin-derivater og deres anvendelse som neurokinin antagonister
NO20043580D0 (no)	2004-08-27	Quinazolinonderivater og deres bruk som CB agonister
DE602005011593D1 (de)	2009-01-22	Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
ATE445402T1 (de)	2009-10-15	Neue verwendung von pde5-hemmern
PE20100084A1 (es)	2010-02-05	Combinacion farmaceutica
FI20040971L (fi)	2006-01-10	Solujen kasvatusalusta ja sen käyttö